Conversely, chronic inflammation of the intestine in inflammatory bowel disease (IBD), a clinically heterogenous group of disorders, may be driven by the proinflammatory effects of IgG, activating local FcγR‐expressing cells72, 73, 74, 75 (Figure 1). The gene discussed is FCGR2A; the disease is inflammatory bowel disease.